home / stock / ensc / ensc quote
Last: | $3.29 |
---|---|
Change Percent: | 6.65% |
Open: | $3.09 |
Close: | $3.29 |
High: | $3.49 |
Low: | $3.08 |
Volume: | 907,554 |
Last Trade Date Time: | 04/25/2025 03:40:13 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.29 | $3.09 | $3.29 | $3.49 | $3.08 | 907,554 | 04-25-2025 |
$3.31 | $3.21 | $3.31 | $3.38 | $3.02 | 1,698,394 | 04-24-2025 |
$3.67 | $4.23 | $3.67 | $4.85 | $3.26 | 92,054,275 | 04-23-2025 |
$1.87 | $1.69 | $1.87 | $1.9 | $1.6776 | 81,761 | 04-22-2025 |
$1.66 | $1.75 | $1.66 | $1.75 | $1.62 | 82,579 | 04-21-2025 |
$1.76 | $1.8 | $1.76 | $1.82 | $1.71 | 133,329 | 04-18-2025 |
$1.76 | $1.8 | $1.76 | $1.82 | $1.71 | 133,329 | 04-17-2025 |
$1.88 | $2.1 | $1.88 | $2.1 | $1.8 | 367,789 | 04-16-2025 |
$2.24 | $1.97 | $2.24 | $2.39 | $1.84 | 1,995,561 | 04-15-2025 |
$1.96 | $2.03 | $1.96 | $2.11 | $1.81 | 82,576 | 04-14-2025 |
$2.03 | $1.83 | $2.03 | $2.12 | $1.76 | 72,045 | 04-11-2025 |
$1.88 | $1.99 | $1.88 | $2.04 | $1.7 | 126,296 | 04-10-2025 |
$1.87 | $1.95 | $1.87 | $2 | $1.75 | 82,289 | 04-09-2025 |
$1.86 | $2.07 | $1.86 | $2.155 | $1.85 | 68,710 | 04-08-2025 |
$1.995 | $2.3 | $1.995 | $2.3105 | $1.99 | 146,016 | 04-07-2025 |
$2.29 | $2.29 | $2.29 | $2.33 | $2.17 | 40,783 | 04-04-2025 |
$2.29 | $2.55 | $2.29 | $2.5555 | $2.24 | 78,350 | 04-03-2025 |
$2.64 | $2.68 | $2.64 | $2.7026 | $2.19 | 125,743 | 04-02-2025 |
$2.5 | $2.6 | $2.5 | $2.68 | $2.4601 | 81,203 | 04-01-2025 |
$2.56 | $2.91 | $2.56 | $3.135 | $2.5394 | 61,443 | 03-31-2025 |
News, Short Squeeze, Breakout and More Instantly...
Ensysce Biosciences Inc. Company Name:
ENSC Stock Symbol:
NASDAQ Market:
6.65% G/L:
$3.29 Last:
907,554 Volume:
$3.09 Open:
$3.29 Close:
Ensysce Biosciences Inc. Website:
2025-04-23 11:26:43 ET DENVER, Colo., Apr 23, 2025 ( 247marketnews.com )- Low-priced stocks with tight floats and compelling catalysts are fueling trader excitement, offering opportunities for quick gains amid volatile markets. Today, 247marketnews.com highlights five NASDAQ stocks to w...
~ Analgesic Experts Consider Pain Indications Versus New Classes of Analgesics ~ ~ Panel Discussion Posted to Ensysce's Corporate Website ~ SAN DIEGO, CA / ACCESS Newswire / March 18, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage ...
SAN DIEGO, CA / ACCESS Newswire / March 5, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced i...